Latest Price Targets from the World's Best Analysts & Research Firms
| Analyst & Firm | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
|
BOAS
11351
B of A Securities
Ruplu Bhattacharya
|
Jabil
JBL
$22.4B
| $209.22 | $245 |
17%
upside
| Buy |
20 Jun ‘25
2 months ago |
|
|
BOAS
11352
B of A Securities
Joseph Tumillo
|
Kinsale Capital Group
KNSL
$10.5B
| $442.30 | $543 |
23%
upside
| Buy |
20 Jun ‘25
2 months ago |
|
|
JM
11353
JP Morgan
Paul Coster
|
Array Technologies
ARRY
$1.34B
| $7.92 | $13 |
64%
upside
| Overweight |
20 Jun ‘25
2 months ago |
|
|
RC
11354
RBC Capital
Leonid Timashev
|
CorMedix
CRMD
$952M
| $13.03 | $17 |
30%
upside
| Outperform |
20 Jun ‘25
2 months ago |
|
|
DD
11355
DA Davidson
Gil Luria
|
Nice
NICE
$8.83B
| $143.35 | $195 |
36%
upside
| Buy |
20 Jun ‘25
2 months ago |
|
|
RC
11356
RBC Capital
Leonid Timashev
|
ADC Therapeutics
ADCT
$396M
| $3.32 | $5 |
51%
upside
| Outperform |
20 Jun ‘25
2 months ago |
|
|
G
11357
Guggenheim
Debjit Chattopadhyay
|
Ultragenyx Pharmaceutical
RARE
$3.04B
| $31.50 | $64 |
103%
upside
| Buy |
20 Jun ‘25
2 months ago |
|
|
JS
11358
JMP Securities
Aaron Hecht
|
Lennar Class A
LEN
$36.9B
| $137.45 | $130 |
5%
downside
| Market Outperform |
20 Jun ‘25
2 months ago |
|
|
B
11359
Baird
Craig Kennison
|
Patrick Industries
PATK
$3.77B
| $111.87 | $90 |
20%
downside
| Neutral |
20 Jun ‘25
2 months ago |
|
|
JS
11360
JMP Securities
Constantine Davides
|
Evolent Health
EVH
$1.12B
| $9.99 | $13 |
30%
upside
| Market Outperform |
20 Jun ‘25
2 months ago |
|
|
W
11361
Wedbush
Daniel Ives
|
Nice
NICE
$8.83B
| $143.35 | $200 |
40%
upside
| Outperform |
20 Jun ‘25
2 months ago |
|
|
WF
11362
Wells Fargo
Michael Blum
|
Array Technologies
ARRY
$1.34B
| $7.92 | $8 |
1%
upside
| Equal-Weight |
20 Jun ‘25
2 months ago |
|
|
W
11363
Wedbush
Robert Driscoll
|
Kura Oncology
KURA
$707M
| $8.01 | $36 |
349%
upside
| Outperform |
20 Jun ‘25
2 months ago |
|
|
WF
11364
Wells Fargo
Derek Archila
|
ATYR
aTyr Pharma
ATYR
$535M
| $5.31 | $25 |
371%
upside
| Overweight |
20 Jun ‘25
2 months ago |
|
|
W
11365
Wedbush
Jay McCanless
|
Builders FirstSource
BLDR
$16.3B
| $140.45 | $145 |
3%
upside
| Outperform |
20 Jun ‘25
2 months ago |
|
|
B
11366
Barclays
David Anderson
|
Helmerich & Payne
HP
$1.99B
| $20.02 | $17 |
15%
downside
| Equal-Weight |
20 Jun ‘25
2 months ago |
|
|
W
11367
Wedbush
Daniel Ives
|
IBM
IBM
$239B
| $259.11 | $325 |
25%
upside
| Outperform |
20 Jun ‘25
2 months ago |
|
|
C
11368
CICC
|
Snowflake
SNOW
$76.7B
| $225.56 | $225 |
0%
downside
| Outperform |
20 Jun ‘25
2 months ago |
|
|
WR
11369
Wolfe Research
Steven Chubak
|
TPG
TPG
$8.72B
| $58.95 | $60 |
2%
upside
| Outperform |
20 Jun ‘25
2 months ago |
|
|
M
11370
Macquarie
Chad Beynon
|
Sportradar
SRAD
$9.17B
| $31.18 | $32 |
3%
upside
| Outperform |
20 Jun ‘25
2 months ago |
|
|
WF
11371
Wells Fargo
Cerena Chen
|
MTSR
Metsera, Inc. Common Stock
MTSR
$3.69B
| $36.72 | $65 |
77%
upside
| Overweight |
20 Jun ‘25
2 months ago |
|
|
WF
11372
Wells Fargo
Chris Carey
|
Mondelez International
MDLZ
$80.1B
| $62.57 | $78 |
25%
upside
| Overweight |
20 Jun ‘25
2 months ago |
|
|
R
11373
Rosenblatt
Barton Crockett
|
Atlanta Braves Holdings Series B
BATRK
$2.66B
| $42.01 | $69 |
64%
upside
| Buy |
20 Jun ‘25
2 months ago |
|
|
R
11374
Rosenblatt
Mike Genovese
|
Viavi Solutions
VIAV
$2.59B
| $11.69 | $13.50 |
15%
upside
| Buy |
20 Jun ‘25
2 months ago |
|
|
N
11375
Needham
Mayank Tandon
|
Equifax
EFX
$31.2B
| $252.01 | $295 |
17%
upside
| Buy |
20 Jun ‘25
2 months ago |
|